Finance

Lists
Why is 541540 up 6,66%?
Dive Deeper
541540:BOM
Solara Active Pharma Sciences Ltd
₹696,30
+6,66%
(+43,50) 1D
16 Okt., 15:54:41 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 541540...
Open
₹649,55
High
₹759,60
Low
₹645,60
Mkt. cap
33,53 mjd
Avg. vol.
26,07 k
Volume
190,84 k
52-wk high
₹774,00
52-wk low
₹422,85
EPS
-₹0,67
Shares outstanding
24,67 m
No. of employees
2 k
Open
₹649,55
High
₹759,60
Low
₹645,60
Mkt. cap
33,53 mjd
Avg. vol.
26,07 k
Volume
190,84 k
52-wk high
₹774,00
52-wk low
₹422,85
EPS
-₹0,67
Shares outstanding
24,67 m
No. of employees
2 k
News stories
From web sources and news partners
About Solara Active Pharma Sciences Ltd
CEOPoorvank Purohit
Employees1,67 k
Founded2017
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,14 mjd
3,49 mjd
3,87 mjd
3,82 mjd
Cost of goods sold
1,54 mjd
1,87 mjd
2,46 mjd
1,96 mjd
Cost of revenue
1,54 mjd
1,87 mjd
2,46 mjd
1,96 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
548,60 m
552,30 m
596,40 m
560,50 m
Operating expense
1,49 mjd
1,51 mjd
1,09 mjd
1,50 mjd
Total operating expenses
3,03 mjd
3,37 mjd
3,55 mjd
3,46 mjd
Operating income
102,40 m
117,70 m
326,90 m
352,60 m
Other non operating income
4,90 m
-
-74,50 m
26,90 m
EBT including unusual items
-101,00 m
-174,30 m
96,00 m
163,10 m
EBT excluding unusual items
-101,00 m
-106,80 m
82,50 m
163,10 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
699,50 m
698,30 m
229,70 m
671,50 m
Net income
-101,00 m
-174,30 m
96,00 m
163,10 m
Net profit margin
-3,22%
-4,99%
2,48%
4,27%
Earnings per share
-
-
-
-
Interest and investment income
-
-
13,70 m
-
Interest expense
-208,30 m
-224,50 m
-214,20 m
-216,40 m
Net interest expenses
-208,30 m
-224,50 m
-200,50 m
-216,40 m
Depreciation and amortization charges
244,90 m
255,70 m
260,40 m
267,10 m
EBITDA
342,75 m
354,30 m
562,52 m
601,80 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme